Colitis in test mice responds to treatment with human umbilical cord-derived mensenchymal cells

April 23, 2012

When laboratory mice were modeled with colitis and treated with human umbilical cord-derived mesenchymal cells, the cells homed in on the inflamed colon and effectively ameliorated colitis, reported a study published in a recent issue of Cell Transplantation (20:9), now freely available online.

According to study corresponding author Dr. Zhong Chao Han of the Institute of Hematology, Chinese Academy of Sciences and Peking Union of Medical Sciences, Crohn's disease and are two forms of inflammatory bowel diseases with uncertain etiologies. Their study was designed to determine if human umbilical cord-derived mesenchymal cells (hUC-MSCs) would be therapeutic when transplanted to test mice modeled with acute colitis.

"Emerging data has shown that MSCs have broad and potent immunosuppressive activities," said Dr. Han. "Our study found that systematic administration of hUC-MSCs effectively attenuated the clinical and pathological severity of the induced colitis by several disease parameters, including body weight loss and infiltration of ."

Colitis was induced in the test animals by use of trinitrobenzene sulfonic acid (TNBS), which was found to induce high levels of pro-inflammatory cytokines. However, the increased expression of cytokines interleukin (IL)-23 and IL-17 was "significantly reversed by hUC-MSC infusion."

"Although our study demonstrated that hUC-MSCs could inhibit the acute inflammatory process, the effect of the same treatment on is an unknown and should be investigated," said Dr Han.

Additionally, the researchers reported that once the hUC-MSCs migrated to the inflamed colon, they remained there for several weeks, indicating to the researchers that the hUC-MSCs were not only "responsive to the cues sent by the injured colon tissues" but were also "well tolerated, even in the xeno-transplantation setting."

"Considering that hUC-MSCs can be readily isolated with no harm to donors and subsequently expanded rapidly in large quantities, they provide an excellent choice for future clinical applications," concluded Dr. Han and the study's co-authors.

"This study provides preliminary evidence that umbilical cord derived mesenchymal stem cells acutely reduces the inflammation that causes colitis," said Dr. Shinn-Zong Lin, professor of Neurosurgery and superintendent at the China Medical University Hospital of Taichung, Taiwan. "The next step will be to see if long term benefit can also be demonstrated".

Explore further: Umbilical cord blood-derived stem cells studied for lupus therapy

More information: Liang, L.; Dong, C.; Chen, X.; Fang, Z.; Xu, J.; Liu, M.; Zhang, X.; Gu, D. S.; Wang, D.; Du, W.; Zhu, D.; Han, Z. C. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant. 20(9):1395-1408; 2011.

Provided by: Cell Transplantation Center of Excellence for Aging and Brain Repair


Related Stories

Novel cytokine protects mice from colitis

August 23, 2011

Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed ...

Recommended for you

Researchers grow retinal nerve cells in the lab

November 30, 2015

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. ...

Shining light on microbial growth and death inside our guts

November 30, 2015

For the first time, scientists can accurately measure population growth rates of the microbes that live inside mammalian gastrointestinal tracts, according to a new method reported in Nature Communications by a team at the ...

Functional human liver cells grown in the lab

November 26, 2015

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.